Literature DB >> 2418692

Immunohistochemical staining for vimentin and keratin in malignant mesothelioma.

A Churg.   

Abstract

Because tissue culture studies have suggested that mesothelial cells might produce large amounts of vimentin, I stained eight mesotheliomas (two fixed in alcohol) for vimentin using the Gown and Vogel monoclonal antibody 43 beta E8. The two tumors that had alcohol fixed blocks were strongly positive for vimentin, whereas one of the tumors fixed only in formalin showed moderately strong staining and two others showed very weak focal positivity; the remaining tumors were negative. In the mesotheliomas that did stain, both epithelial and spindled elements gave a positive reaction. Three alcohol-fixed lung cancers and two blocks of alcohol-fixed pleura failed to stain for vimentin. By contrast, all mesotheliomas and carcinomas, whether alcohol or formalin fixed, as well as sections of pleura, were strongly positive when stained with anticytokeratin antibody 35 beta H11. I conclude that the combination of staining for vimentin and keratin might be a useful diagnostic finding in malignant mesothelioma, but that specially fixed material is required for reliable vimentin staining.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2418692     DOI: 10.1097/00000478-198505000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

Review 1.  Malignant mesothelioma.

Authors:  R Rudd
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

2.  Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study.

Authors:  J M Theaker; K C Gatter; M M Esiri; K A Fleming
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

3.  Immunohistochemistry in the diagnosis of malignant mesothelioma.

Authors:  M Pfaltz; B Odermatt; B Christen; J R Rüttner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1.

Authors:  M L Warnock; A Stoloff; A Thor
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

5.  Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings.

Authors:  H Moch; M Oberholzer; P Dalquen; W Wegmann; F Gudat
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3--a new tumor marker.

Authors:  C S Kortsik; P Werner; N Freudenberg; J C Virchow; C Kroegel; M Pott; H Matthys
Journal:  Lung       Date:  1995       Impact factor: 2.584

7.  Mesothelioma-like tumors of the pleura: a review of 72 autopsy cases.

Authors:  C A Hartmann; H Schütze
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Malignant mesothelioma.

Authors:  E Heyderman; P D Ridley
Journal:  J R Soc Med       Date:  1989-09       Impact factor: 18.000

9.  Pleural mesothelioma in a nine-month-old dog.

Authors:  Sevil Atalay Vural; Zafer Ozyildiz; Sule Yurdagul Ozsoy
Journal:  Ir Vet J       Date:  2007-01-01       Impact factor: 2.146

10.  NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB.

Authors:  Yali Cheng; Liying Xie; Zhiying Xu; Mengxin Hao; Bingyi Yang; Weiwei Shan; Yiqin Wang; Qiaoying Lv; Xiaojun Chen
Journal:  Cancer Gene Ther       Date:  2022-04-06       Impact factor: 5.854

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.